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EFECTOS DE LA SUPLEMENTACION
CON CREATINA EN PRACTICANTES
DE TAEKWONDO
Resumen
Introducción: El Taekwondo (TKD) es un arte marcial,
que ha sido propuesto también en programas de activi-
dad física, con un fuerte componente anaeróbico. La
suplementación con creatina (Cr), utilizada para mejorar
el rendimiento deportivo y la composición corporal,
puede ser beneficiosa en TKD.
Objetivos: Determinar el efecto de la suplementación
de Cr sobre la composición corporal, potencia anaeróbica
y bioquímica sanguínea en practicantes jóvenes de TKD.
Métodos: Diez practicantes varones de TKD (edad [20
± 2 años], estatura [1,69 ± 0,06 m], peso [67,0 ± 9,8 kg])
participaron en un ensayo aleatorizado cruzado (grupo
control + placebo). Se evaluaron (pre-post suplementa-
ción) la composición corporal (DEXA), la potencia anae-
róbica (Test de Wingate), el lactato y la bioquímica san-
guínea. Se calculó la diferencia entre los valores pre y post
ingestión para ambos tratamientos (Cr y placebo) y se
compararon las diferencias usando la prueba de signos y
rangos de Wilcoxon.
Resultados: La masa grasa (kg) disminuyó después del
placebo (Mdn [IqR] = -0,75 [-1,44 a 0,03]) mientras que
con Cr se elevó significativamente (0,17 [-0,77 a 1,13] kg)
(Z = 2,191, p < 0,028, r = 0,49). La concentración sanguí-
nea de triglicéridos (mg/mL) aumentó con Cr (45,00 [-
7,50 a 75,00]) y disminuyó con Placebo (-7,00 [-10,75 a
12,00]) (Z = 2,090, p < 0,037, r = 0,47). No hubo cambios
significativos en otros parámetros.
Conclusiones: La suplementación con creatina puede
incrementar la masa grasa y la concentración sanguínea
de triglicéridos en jóvenes practicantes de TKD, sin mejo-
rar la potencia anaerobia. La suplementación parece ser
segura, pero es necesario ser cuidadosos cuando se busca
disminuir el peso corporal.
(Nutr Hosp. 2013;28:391-399)
DOI:10.3305/nh.2013.28.2.6314
Palabras clave: Suplemento nutricional. Artes marciales.
Grasa corporal. Test de Wingate. Triglicéridos.
Abstract
Introduction: Taekwondo (TKD) is a combat sport,
which has also been proposed as a fitness program, with a
strong anaerobic component. Creatine (Cr) supplemen-
tation is used to improve both anaerobic exercise perfor-
mance and body composition. Therefore, Cr supplemen-
tation could be beneficial in TKD.
Aims: To determine the effect of Cr supplementation
(50 mg/kg body wt) on body composition, anaerobic
power and blood chemistry in young male TKD practitio-
ners.
Methods: Ten male TKD practitioners (age [20 ± 2 yr],
height [1.69 ± 0.06 m], and mass [67 ± 9.8 kg]) partici-
pated in a placebo-controlled, double blind, crossover
study. Body composition (DEXA), anaerobic power
(Wingate Test), blood lactate and blood chemistry were
measured before and after supplementation. Differences
between data before and after supplementation were
calculated for each treatment (Cr and Placebo) and were
compared using the Wilcoxon signed-rank test.
Results: Fat mass (kg) decreased after placebo (Mdn
[IqR] = -0.75 [-1.44 to 0.03]) and increased following Cr
intake (0.17 [-0.77 to 1.13] kg) (Z = 2.191, p < 0.028, r =
0.49). Serum triglyceride concentration (mg/mL) increa -
sed after Cr (45.00 [-7.50 to 75.00]) and decrease with
placebo (-7.00 [-10.75 to 12.00]) (Z = 2.090, p < 0.037, r =
0.47). No changes were found in others parameters.
Conclusion: Cr supplementation may increase fat mass
and serum triglycerides concentration in young male
TKD practitioners without improvement in anaerobic
power. Cr supplementation appears to be safe, but
athletes should be careful when they want to loss fat.
(Nutr Hosp. 2013;28:391-399)
DOI:10.3305/nh.2013.28.2.6314
Key words: Dietary supplement. Martial arts. Wingate
test. Body fat. Triglycerides.
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Abbreviations
ATP: Adenosine triphosphate.
BF%: Body fat percentage.
BFLM: Bone free lean mass.
BM: Total body mass.
BMC: Bone mineral content.
Cr: Creatine.
DEXA: Dual energy x ray absorbtiometer.
FM: Fat mass.
PCr: Phospocreatine.
TKD: Taekwondo.
Introduction
Taekwondo (TKD) is a combat sport and an
Olympic discipline with about one million of practitio-
ners worldwide.1 TKD has also been proposed as a
fitness program highly demanding for most muscle
groups of the body.1,2 Although TKD improves both
aerobic and anaerobic capacities,3,4 some studies
suggest that anaerobic metabolism is the main source
of energy in TKD.1,4,5
Phosphocreatine (PCr) is one the most important
substrates for adenosine triphosphate (ATP) re-syn -
thesis during high intensity exercise bouts, and it is
generally accepted that the development of fatigue
during maximal short duration exercise is associated
with the depletion of muscle PCr stores.6 Creatine (Cr)
and PCr serve to continuously preserve intracellular
ATP availability, modulate metabolism and buffer ion
accumulation during muscle contraction.6 Hultman et
al.7 were the first to describe that muscle total Cr
concentration increased by approximately 20% in
young men after 6 days of Cr supplementation at a rate
of 20 g/day or 3 g/day by 28 days. This elevated
concentration was maintained when supplementation
was continued at a rate of 2 g/day for a further 30 days.
After that, athletes have used Cr supplementation in an
attempt to improve exercise performance by delaying
PCr depletion and the rate of adenosine diphosphate
(ADP) accumulation during maximal exercise, to
promote PCr re-synthesis during repeated bouts of
maximal short-duration exercise, and to optimize body
composition.8,9 Nevertheless, it has been suggested that
high doses of Cr supplementation (20 g) may be related
to renal or liver damage,10,11 gastrointestinal discomfort,12
dehydration and muscle cramping;13 whereas low doses
(3 to 7 g) have been shown to be safe and effective.7,14
In all TKD practitioners, athletes and non-athletes, the
most desirable characteristics are low levels of body
fat,4,5 high anaerobic abilities,3-5,16 elevated aerobic
fitness,3,4,15,16 strength,4,15 and flexibility.4,15 To our know-
ledge, although Cr supplementation should be beneficial
in TKD due to its role as energy source, there is no re -
search examining the effects of Cr supplementation in
TKD players. Therefore, the purpose of the present
study was to conduct a placebo-controlled, double blind,
crossover study to determine the effect of oral Cr supple-
mentation on body composition, anaerobic power and
blood chemistry of young TKD practitioners.
Materials and methods
Subjects
Twelve healthy, non-smoking, non-vegetarian, red
and black belt male recreational TKD players (age = 20
± 2 yr; height = 1.69 ± 0.06 m, mass = 67.0 ± 9.8 kg)
were recruited from the Universidad Autónoma del
Estado de México’s team. They had a training history
of 3-5 years. All subjects were free from chronic
disease and were not regularly taking medical prescrip-
tion, were not consuming any ergogenic aids and had
never been supplemented with Cr. Subjects were fully
informed of all procedures and signed a consent form
prior to the study, which carried the approval of the
University Ethics Committee, in according to the prin-
ciples of the Declaration of Helsinki.
Subjects trained normally (3 times per week; ~2 hours
per day) before the study. The typical TKD training
session consisted of three phases: (a) a 30 minute warm-
up period during which non-TKD activities (10 min
running, and 20 min flexibility exercises) were
performed to prepare for higher intensity activities; (b) a
60 minute period after the warm up in which TKD
fundamental techniques (sets of punches, kicks, blocks,
etc.) were performed and repeated with gradually increa-
sing intensity; and (c) a 20 minute cool-down period
divided into 10 min of running and walking performed to
gradually reduce the heart rate to the levels reached at
the end of the warm up period and then 10 min of flexibi-
lity exercise to finish the session. This same training
schedule was maintained during the study.
Supplementation protocol and 
experimental procedure
A double-blind, crossover design was utilized where
subjects were randomly assigned to either groups A or B
which received for 6 weeks either Cr supplementation
(experimental treatment) or placebo (control treatment),
respectively. After a 6-week wash-out period, groups
were then assigned to the opposite treatment for another
6 weeks (fig. 1). Experimental treatment consisted of 1
dose of Cr/day (50 mg/kg body weight per dose) for 6
weeks. Each dose was provided by means of a soft drink
with ~3.5 g of Cr monohydrate (Future Foods, Dover,
NJ, USA; batch number 050467 with 99.92% reported
purity), 30 g of sucrose, artificial flavoring and food
coloring in a water volume of 500 ml. Control treatment
consisted of the same soft drink; but, with 3.5 g of malto-
dextrine, instead of Cr, as placebo. Both soft drinks had
similar taste and appearance and were placed in generic
bottles with a personal code for each subject to ensure
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double-blind administration. On training days, subjects
consumed 250 mL of soft drink one hour before exercise
and the rest of the drink immediately after exercise. On
non- training days, subjects consumed the soft drink any
time during the day. Also, subjects were instructed to
maintain their same diet during the study assuming no
changes in their dietary habits due to their controls were
themselves. In addition, subjects were concentrated in
the sports facilities of the Universidad Autónoma del
Estado de México, from Sunday (9 hrs) to Monday (9
hrs), in each trial in order to control food ingestion
before blood sampling and evaluated anaerobic power.
During both Sunday and Monday, all subjects had the
same food menu, which was elaborated for a qualified
nutritionist. Finally, compliance was 4/6 for Group A
and 6/6 for Group B; two subjects in group A were
excluded because of an injury during, but unrelated, to
training (fig. 2).
Body composition
DEXA (dual energy x ray absorbtiometer) is the most
common and reliable method for the analysis of the body
composition.17,18 It was assessed using a fan beam DEXA
Prodigy model (GE/Lunar Corp, Madison, Wisconsin,
USA). We determined total body mass (BM), bone free
lean mass (BFLM), bone mineral content (BMC), fat
mass (FM) and body fat percentage (BF%).
Subjects were tested between 18 and 20 hrs on
Fridays and Saturdays before the Wingate test, or
between 10 and 12 hrs on Mondays after the Wingate
test. Each individual subject was tested at the same
time of day for each trial. All participants were
requested to take off all removable objects containing
metal (i. e. clothing with buttons and/or zippers, jewe-
llery, watch, etc.) before scanning. Scans were
performed with subjects lying in a supine position
along the scanning table’s centerline longitudinal axis.
They were instructed to maintain their hands in a prone
position, and their legs and hands immobilized within
the scanning region during study.
Anaerobic power
Anaerobic power was determined using the 30 s
Wingate anaerobic test. One week before first trial,
subjects had a familiarization session. In this session,
detailed instructions were given to the subjects about
Wingate test procedures and they performed it twice;
also, both the optimal seat height and the maximal peda-
ling speed were determined for each subject and they
were recorded in order to replicate it in subsequent tests.
On test sessions, subjects were evaluated on
Sundays between 10 and 14 hrs, each subject was
tested individually at the same time of the day in every
trial. On arrival at the laboratory, subjects were
weighed and their BM (kg) was recorded to calculate
the load to apply during the test. The test was
performed on a calibrated cycle ergometer (Monark
Ergomedic 818 E, Stockholm, Sweden) equipped with
toe clips with straps to avoid feet slip out of the pedals.
A warm-up period was performed, which comprised
light intensity cycling without load for 2-4 min
reaching a heart rate between 150 and 160 beats/min;
after that, subjects rested for 3 min before the test on
the cycle ergometer. Then, at the researcher’s
command, subjects started to pedal quickly to reach
their maximal pedaling speed, previously recorded;
when they get at it, a load of 7.5% of subject’s BM
(kg)19 was applied and pedal revolutions were recorded.
Subjects were verbally motivated to maintain as high
pedaling rate as possible throughout the 30 s test. We
determined the maximum anaerobic power (the highest
power achieved at any given 5 s period in watts [W]),
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Fig. 1.—Experimental design of the study. Participants were randomized into two groups: group A (n = 6) was supplemented with Cr
for a 6-week period and, after a wash-out period, ingested placebo for another 6-week period; group B (n = 6) ingested placebo for a
6-week period and, after the wash-out period, was supplemented with Cr for another 6-week period.
Tr
ea
tm
en
t Creatina
Placebo
Group A
Group B
Group B
Group A
Period I Washout Period Period II
0 3 6 9 12 15 18
Time (weeks)
Trial Baseline Final Baseline Final
17. EFFECTS_01. Interacción  14/03/13  08:27  Página 393
medium anaerobic power (the average power of the
entire 30 s test in W), and the fatigue index (maximum
anaerobic power minus the lowest power output at any
5 s period and it divided by the maximum anaerobic
power; and expressed as a percentage [%]).
Capillary blood samples were obtained from a
finger-tip puncture, after 5 min of recovery from the
Wingate test,20 and blood lactate concentration
(mmol/L) was determined by means of a portable
Lactate analyzer (Accutrend Lactate, Roche Diagnos-
tics, Mannheim, Germany).21
Blood chemistry
Blood sampling was carried out before and after of
both supplementation periods. After an overnight fast,
subjects reported to the laboratory between 7 and 9 hrs.
Blood samples (~10 mL) were collected from the ante-
cubital vein with minimal stasis by venipuncture into
evacuated serum separation tubes (Vacutainer®, Becton
Dickinson, USA). Serum separation tubes were centri-
fuged for 10 min at 2,500 rpm to separate serum. Serum
samples were subsequently analyzed for glucose, urea,
serum creatinine, triglycerides and total cholesterol
concentration (mg/dL), and enzymes activities (alanine
amine transferase, aspartate amine transferase, gamma-
glutamiltransferase, lactate dehydrogenase; IU/L).
Analysis of samples was carried out with commercial
reagents (Randox Laboratories Ltd., United Kingdom)
in an automated chemistry analyser (Vitalab Selectra-2,
Merck, México).
Statistical analysis
For statistical analysis, data from period I and II of
both groups A and B (fig. 1) were grouped by treatment
(Cr or placebo); and differences between baseline and
final trials were calculated for each treatment. Results
from differences of both treatments were compared using
the Wilcoxon signed-rank test for all variables. Signifi-
cance level was set at the level of p < 0.05; and the effect
of size (r) was calculated by dividing Z from Wilcoxon
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Fig. 2.—Flow chart of parti-
cipants during the study.
Elegible subjects (n = 12)
Randomized subjects (n = 12)
Group A (n = 6)
Received creatine allocated (n = 6)
in the 1st treatment period
Received placebo allocated (n = 4)
in the 2nd treatment period
Two dropouts [injury (n = 2)]
Analyzed (n = 4) Analyzed (n = 6)
Followed up (n = 4)
Assessments of efficacy measures: 18 weeks,
2 treatment periods and 4 trials
Followed up (n = 6)
Assessments of efficacy measures: 18 weeks,
2 treatment periods and 4 trials
No dropouts
Received creatine allocated (n = 6)
in the 2nd treatment period
Received placebo allocated (n = 6)
in the 1st treatment period
Group B (n = 6)
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signed-rank test by the square root of the total number of
subjects. All results are expressed as Median (Mdn) and
Interquartile Range (IqR; percentile 25th to 75th). Data
analyses were performed on SPSS© for Windows®
(version 15.0, SPSS Inc., Chicago, Illinois, USA).
Results
Subjects
At the end of the each supplementation period,
subjects were asked whether they were aware of the
treatment they had received. After either experimental
or control treatment, all subjects reported that they
were unsure about the treatment. No signs of gastroin-
testinal distress, muscle cramping or any other side
effects were reported.
Body composition
Results of DEXA analysis are shown in table I. There
was a significant difference between treatments in FM
(Z = 2.191, p < 0.028, r = 0.49); subsequent to placebo
administration, subjects FM decreased whereas after Cr
supplementation it increased. Comparing FM results
from treatments for each subject; we observed that 7
subjects in placebo treatment had a decrease in FM
whereas 2 had an increase, and only one did no change
(fig. 3). On the contrary, 6 subjects in Cr treatment
increased their FM, whereas had a decrease (fig. 3).
Also, we noticed that two subjects, who decreased FM
after Cr supplementation, had a larger decrease after
placebo supplementation (fig. 3). No differences were
observed for BM, BFLM, BMC or BF%.
Anaerobic power
Results of the 30s Wingate anaerobic test are shown
in table II. Non-significant differences between treat-
ments were found in anaerobic power variables. In
addition, no significant differences were observed in
blood lactate concentration (table III).
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Fig. 3.—Individual differences in body fat mass.
Table I
Body composition by DEXA
Treatment [Mdn (IqR)]
Trial Placebo Creatine
Body mass (kg) Baseline 66.91 (58.63 to 71.70) 68.43 (58.63 to 73.10)Final 66.74 (58.63 to 70.74) 69.06 (58.43 to 74.47)
Δ -0.17 (-1.15 to 0.73) 0.29 (-0,43 to 2.11)
Bone free lean mass (kg) Baseline 51.78 (45.71 to 55.53) 51.37 (46.36 to 55.83)
Final 50.71 (46.96 to 56.24) 51.87 (46.86 to 55.47)
Δ 1.00 (-1.00 to 1.51) 0.62 (-0,71 to 1.20)
Bone mineral content (kg) Baseline 3.06 (2.94 to 3.26) 3.06 (3.00 to 3.27)
Final 3.06 (2.93 to 3.28) 3.06 (2.97 to 3.32)
Δ 0.00 (-0.02 to 0,02) 0.00 (-0.01 to 0.02)
Fat mass (kg) Baseline 11.43 (8.97 to 14.56) 11.71 (8.59 to 16.19)
Final 10.26 (7.95 to 13.33) 12.54 (8.32 to 14.85)
Δ -0.75 (-1,44 to 0.03) 0.17 (-0.77 to 1.13)*
Body fat (%) Baseline 17.70 (15.03 to 23.23) 18.85 (15.13 to 22.60)
Final 16.45 (12.20 to 22.30) 18.55 (14.93 to 23.20)
Δ -0.85 (-2.13 to -0.15) 0.05 (-1.43 to 1.65)
Data are Mdn (IqR) = Median (Interquartile Range [percentile 25th to 75th]) from n = 10 subjects; Δ = Final-Baseline; *p < 0.05 vs. placebo from
Wilcoxon signed-rank tests.
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Table II
Anaerobic power by Wingate test
Treatment [Mdn (IqR)]
Trial Placebo Creatine
Maximum anaerobic power (W) Baseline 518.7 (427.4 to 572.3) 473.6 (426.9 to 583.9)Final 601.1 (448.0 to 637.4) 590.7 (464.6 to 694.5)
Maximum anaerobic power Δ 40.7 (13.96 to 62.77) 51.9 (19.58 to 171.62)
(W/kg of BM) Baseline 7.28 (6.94 to 8.53) 6.99 (6.16 to 7.87)Final 8.13 (7.41 to 9.21) 8.09 (6.42 to 10.36)
Δ 0.55 (0.08 to 1.25) 0.67 (0.07 to 2.23)
Medium anaerobic power (W) Baseline 449.5 (364.45 to 499.13) 401.6 (383.09 to 500.95)
Final 520.3 (404.29 to 541.53) 480.0 (420.72 to 580.58)
Medium anaerobic power Δ 34.5 (16.41 to 57.82) 44.7 (14.44 to 148.11)
(W/kg of BM) Baseline 6.31 (5.76 to 7.50) 5.96 (5.66 to 6.68)Final 7.06 (6.47 to 7.77) 6.65 (5.94 to 8.81)
Δ 0.61 (0.06 to 0.94) 0.54 (0.21 to 2.05)
Fatigue index (%) Baseline 28.99 (24.23 to 33.05) 27.25 (22.42 to 35.24)
Final 33.33 (27.33 to 36.61) 32.56 (26.04 to 37.82)
Δ 3.87 (-2.97 to 9.88) 2.89 (-5.49 to 11.39)
Data are Mdn (IqR) = Median (Interquartile Range [percentile 25th to 75th]) from n = 10 subjects; Δ = Final-Baseline; *p < 0.05 vs. placebo from
Wilcoxon signed-rank tests.
Table III
Blood lactate concentration after 5 min of recovery from the Wingate test, and blood chemistry
Treatment [Mdn (IqR)]
Trial Placebo Creatine
Blood lactate (mmol/L) Baseline 7.16 (4.70 to 9.78) 8.26 (7.00 to 8.95)Final 12.16 (10.35 to 14.20) 9.33 (6.85 to 11.00)
Δ 5.00 (3.48 to 7.99) 0.45 (-1.51 to 3.85)
Glucose (mg/dL) Baseline 83.50 (77.00 to 88.50) 83.50 (82.75 to 88.25)
Final 84.50 (82.50 to 88.50) 88.00 (84.00 to 95.00)
Δ 1.50 (-1.75 to 6.50) 4.00 (-2.00 to 9.50)
Urea (mg/L) Baseline 38.50 (29.00 to 42.75) 29.50 (26.00 to 42.25)
Final 37.00 (29.00 to 41.75) 34.50 (32.25 to 37.00)
Δ -0.50 (-6.75 to 3.25) 2.50 (-7.50 to 9.00)
Serum creatinine (mg/L) Baseline 1.11 (1.02 to 1.16) 1.09 (1.01 to 1.20)
Final 1.10 (0.99 to 1.20) 1.21 (1.06 to 1.37)
Δ -0.04 (-0.07 to 0.08) 0.11 (0.02 to 0.23)
Total cholesterol (mg/L) Baseline 157.5 (122.00 to 190.75) 166.0 (143.00 to 185.75)
Final 169.5 (124.75 to 194.50) 171.5 (134.50 to 187.50)
Δ 6.0 (-7.50 to 13.50) -1.5 (-10.25 to 8.25)
Triglycerides (mg/L) Baseline 67.50 (52.00 to 94.25) 73.50 (46.75 to 111.50)
Final 62.00 (44.25 to 109.25) 105.50 (68.50 to 157.25)
Δ -7.00 (-10.75 to 12.00) 45.00 (-7.50 to 75.00)*
Data are Mdn (IqR) = Median (Interquartile Range [percentile 25th to 75th]) from n = 10 subjects; Δ = Final-Baseline; *p < 0.05 vs. placebo from
Wilcoxon signed-rank tests.
Blood chemistry
All evaluated blood chemistry parameters were
within normal reference values for healthy Mexican
people. A significant difference (Z = 2.090, p <
0.037, r = 0.47) between treatments was found in
triglycerides concentration (table III). Comparing
results for each subject, we observed that 7 subjects
had an increase in triglycerides after Cr supplemen-
tation, 2 had a decrease, and one maintained the
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same level (fig. 4); whereas, after placebo supple-
mentation 7 decreased and 3 increased triglycerides
concentration (fig. 4). No significant changes were
found for glucose, urea, serum creatinine, and total
cholesterol. Moreover, no significant differences in
serum liver enzymes were found after Cr supple-
mentation (table IV).
Discussion
We studied the effect of oral Cr supplementation (50
mg/kg body weight for six weeks) on body composi-
tion, anaerobic power and blood chemistry of young
male TKD practitioners. To our knowledge, this is the
first study that evaluates Cr supplementation in TKD.
Our results indicate that: (a) after Cr supplementation
fat mass increased whereas it decreased after placebo;
(b) there was an increase in serum triglycerides
concentration after Cr; whereas after placebo it decrea -
sed; (c) not changes were found in anaerobic power;
and (d) there were no changes in liver enzymes after Cr
supplementation.
At the end of placebo supplementation FM decre-
ased; but, after Cr ingestion it increased. It has been
previously reported that, in healthy active men imple-
menting a strength training program, Cr supplementa-
tion (20 g/day for 4 days, then 2g/day for another 17
days) prevents FM and BF% decrease, and results in an
increased respiratory exchange ratio and carbohydrate
utilization.22 Therefore, Cr supplementation may
inhibit normal fat loss through a greater carbohydrate
oxidation and lower fat oxidation. Similar result have
been reported after the ingestion of a supplement
containing Cr (Cr [5 g], glutamine [3 g], and ribose [2
g] plus supplement base formula) and eight weeks of a
resistance training program; in this research subjects
decreased FM and BF% after placebo ingestion with an
absence of changes after Cr ingestion.23
Furthermore, in a study with obese subjects,24 resear-
chers reported that simultaneous treatment with N-
acetylcysteine (0.6 g) plus Cr (2 g) induces a reduction
of ~2.2% in body fat mass; whereas subjects with only
N-acetylcisteine (0.6 g) had a reduction of ~3.6%; and
Creatine supplementation in taekwondo 397Nutr Hosp. 2013;28(2):391-399
Fig. 4.—Individual differences in triglyceride concentration.
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Table IV
Blood enzyme concentrations
Treatment [Mdn (IqR)]
Trial Placebo Creatine
Alanine aminetransferase (IU/L) Baseline 24.50 (17.50 to 29.75) 28.0 (17.25 to 36.25)
Final 33.00 (19.75 to 52.75) 21.00 (18.25 to 26.25)
Δ 5.00 (-2.75 to 25.00) -3.00 (-6.50 to 1.25)
Aspartate aminetransferase (IU/L) Baseline 26.50 (24.75 to 34.50) 30.50 (25.00 to 33.75)
Final 30.50 (25.25 to 37.25) 30.50 (27.75 to 34.50)
Δ 0.00 (-3.00 to 6.75) 0.50 (-6.25 to 7.25)
Gamma-glutamil transferase (IU/L) Baseline 22.25 (16.58 to 24.18) 18.55 (15.23 to 25.15)
Final 20.45 (16.40 to 36.90) 22.05 (14.32 to 26.65)
Δ -0.85 (-4.50 to 5.45) 1.15 (-1.9 to 3.8)
Lactate dehydrogenase (IU/L) Baseline 365.5 (330.0 to 385.7) 373.5 (316.0 to 405.5)
Final 363.5 (330.7 to 393.5) 376.5 (358.7 to 404.2)
Δ 27.5 (-27.25 to 45.75) -7.5 (-22.50 to 35.75)
Data are Mdn (IqR) = Median (Interquartile Range [percentile 25th to 75th]) from n = 10 subjects; Δ = Final-Baseline; *p < 0.05 vs. placebo from
Wilcoxon signed-rank tests.
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subjects with only Cr (2 g) had an increase of 2.3%. In
addition, the reduction produced by N-acetylcisteine
plus Cr was accompanied by a decrease in plasma
glucose levels at 30, 60, and 90 min of oral glucose
tolerance tests, and a significant decrease in insulin
concentration 60 min after glucose administration.24
Authors suggested that Cr improves muscular insulin
reactivity and may reduce body fat without compromi-
sing glucose utilization. Although various previous
studies have reported no significant changes in trigly-
cerides concentration after Cr supplementation in
resistance-trained men,25 basketball player26 and foot-
ball players,27 we observed a significant difference in
triglycerides concentration after Cr supplementation
compared with placebo in the final trial. It has been
suggested that the increase in carbohydrate utilization
induced by Cr may be due to an activation of the
enzyme phosphofructokinase, which produce an
increase in glucose utilization, with elevation of
malonyl-CoA and inhibition of carnitine palmitoyl-
transferase 1 (CPT1) system, which transports fatty
acids into the mitochondria for oxidation.22 If fatty
acids are not transported into the mitochondria of
skeletal muscle cells to be oxidized, they could be
expected to be maintained in blood as triglycerides;
and then stored in the adipose tissue. We observed a
higher concentration of triglycerides after Cr supple-
mentation, and also found that subjects after Cr treat-
ment gained fat mass whereas after placebo treatment
fat was lost. Therefore, both findings could imply that
fatty acid mitochondrial uptake has been inhibited by
Cr ingestion, altering the normal fat loss produced by
TKD training.
Previous studies have shown improvements in anae-
robic power by Cr using a 30 s Wingate Test in elite
wrestlers,28 amateur swimmers,29 untrained male
university students30 and trained young men.20 We did
not find significant differences in anaerobic power in
our subjects, coinciding with reports in strength/power
athletes using a daily supplementation of 10.5 g de Cr
plus a resistance training program for 10 weeks,31 or
healthy subjects receiving Cr (0.1 g/kg/day) during 10
days.32 These mixed results indicate that the effective-
ness of Cr supplementation on power is not always
clear. Moreover, the presence of non-responders33 may
even complicate more the interpretation of results in
studies involving a low number of subjects. Then,
although the slight increase (0.17 kg) in body fat of our
TKD practitioners may be beneficial for practitioners
and athletes who are in their desirable body weight;
TKD practitioner using it as a fitness program or TKD
athletes who are losing weight may have problems to
decrease body fat mass. Moreover, during TKD
competitions, athletes are divided in weight categories,
and practitioners are required to make weight to
compete. Then, on the one hand, Cr supplementation
could help to maintain the desirable weight in TKD
competitors during preparation; but, on the other hand,
TKD practitioners who are losing weight should be
careful to take Cr supplementation due to a the possibly
fat retention.
Finally, in agreement with different previous
studies, no increase in the activity of any liver enzyme
was found following Cr supplementation.34,35 We were
not able to find studies reporting the activity of serum
enzymes in TKD players, being the present the first
report on the safety of low doses of Cr supplementation
in this sport.
Conclusion
In conclusion, oral creatine supplementation (50 m/
kg of body mass for 6 weeks) could help to increase
slightly fat mass in young male TKD practitioners,
suggesting a change in substrate utilization as was
shown by the increase in serum triglycerides, with no
improve of anaerobic power. In addition, we did not
found clinically significant changes in blood chemistry
parameters, which suggest that Cr supplementation, at
the dose used in the present study, appears to be safe for
TKD practitioners, although they must be careful when
fat loss is wanted.
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